Terranueva Corp

Terranueva Corp. Engages in the research and development, innovation, and operation on cannabis based therapeutic treatment. The company is headquartered in L'Assomption, Quebec. The company went IPO on 2018-12-17. The Company, through its subsidiary, Terranueva Pharma Corporation, holds the necessary licenses from Health Canada. The company is focused on providing the Canadian and international markets with first-rate medicinal and recreational cannabis. The firm seeks to develop cannabis that meets the primary motivations of consumers: chronic pain, migraines, sleep disorders and anxiety. Its products may be distributed in clinic, pharmacy, dispensaries, its Website and for direct sale. The firm's Certification, Research and Development Unit (CRDU) is located in L'Assomption, Quebec, Canada. Its production approach is developed according to modular production principles. Its crops are cultivated in a computer-assisted, automated and controlled environment at all times.